Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Detection and prevention of adverse drug events [[electronic resource] ] : information technologies and human factors / / edited by Regis Beuscart, Werner Hackl, Christian Nohr
| Detection and prevention of adverse drug events [[electronic resource] ] : information technologies and human factors / / edited by Regis Beuscart, Werner Hackl, Christian Nohr |
| Pubbl/distr/stampa | Amsterdam ; ; Washington D.C., : IOS Press, c2009 |
| Descrizione fisica | 1 online resource (236 p.) |
| Disciplina |
615.704
615/.10289 |
| Altri autori (Persone) |
BeuscartRégis
HacklWerner <1976-> NøhrChristian |
| Collana | Studies in health technology and informatics |
| Soggetto topico |
Hospitals - Drug distribution systems
Drugs - Side effects Medication errors |
| Soggetto genere / forma | Electronic books. |
| ISBN |
661245461X
1-282-45461-7 9786612454615 1-60750-455-3 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Title page; Preface; Contents; Part A. Keynotes on Patient Safety; Measuring Patient Safety: The Need for Prospective Detection of Adverse Events; The Impact of Commercial Electronic Medication Management Systems on Errors and Clinicians' Work in Hospitals; Patient Safety Through Intelligent Procedures in Medication: The PSIP Project; Human Factors Engineering for Computer-Supported Identification and Prevention of Adverse Drug Events; Decision Support to Avoid Medication Errors . How Far Have We Come in Denmark and What Are the Present Challenges
ReMINE: An Ontology-Based Risk Management PlatformThe EU-ADR Project: Preliminary Results and Perspective; DebugIT: Building a European Distributed Clinical Data Mining Network to Foster the Fight Against Microbial Diseases; Part B. Detection and Prevention of Adverse Drug Events; Detection of Adverse Drug Events: Proposal of a Data Model; Detection of Adverse Drug Events Detection: Data Agregation and Data Mining; The Expert Explorer: A Tool for Hospital Data Visualization and Adverse Drug Event Rules Validation; Application of the Apriori Algorithm for Adverse Drug Reaction Detection Adverse Drug Events Prevention Rules: Multi-Site Evaluation of Rules from Various SourcesAutomatic Indexing in a Drug Information Portal; Implementation of SNOMED CT to the Medicines Database of a General Hospital; A Knowledge Engineering Framework Towards Clinical Support for Adverse Drug Event Prevention: The PSIP Approach; Strategy for Implementation and First Results of Advanced Clinical Decision Support in Hospital Pharmacy Practice Inevitable Components of and Steps for ADE Management Systems: The Need for a Unified Ontological Framework (UOF) and a More Effective Collaboration in Medication SafetyComputerised Physician Order Entry (CPOE); Part C. Human Factors and Adverse Drug Events; CPOE, Alerts and Workflow: Taking Stock of Ten Years Research at Erasmus MC; Contribution of Human Factors for the Review of Automatically Detected ADE; A Framework for Diagnosing and Identifying Where Technology-Induced Errors Come from; Gaming Against Medical Errors: Methods and Results from a Design Game on CPOE The PSIP Approach to Account for Human Factors in Adverse Drug Events: Preliminary Field StudiesThe Problem of Defensive Medicine: Two Italian Surveys; Subject Index; Author Index |
| Record Nr. | UNINA-9910457128203321 |
| Amsterdam ; ; Washington D.C., : IOS Press, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Detection and prevention of adverse drug events [[electronic resource] ] : information technologies and human factors / / edited by Regis Beuscart, Werner Hackl, Christian Nohr
| Detection and prevention of adverse drug events [[electronic resource] ] : information technologies and human factors / / edited by Regis Beuscart, Werner Hackl, Christian Nohr |
| Pubbl/distr/stampa | Amsterdam ; ; Washington D.C., : IOS Press, c2009 |
| Descrizione fisica | 1 online resource (236 p.) |
| Disciplina |
615.704
615/.10289 |
| Altri autori (Persone) |
BeuscartRégis
HacklWerner <1976-> NøhrChristian |
| Collana | Studies in health technology and informatics |
| Soggetto topico |
Hospitals - Drug distribution systems
Drugs - Side effects Medication errors |
| ISBN |
661245461X
1-282-45461-7 9786612454615 1-60750-455-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Title page; Preface; Contents; Part A. Keynotes on Patient Safety; Measuring Patient Safety: The Need for Prospective Detection of Adverse Events; The Impact of Commercial Electronic Medication Management Systems on Errors and Clinicians' Work in Hospitals; Patient Safety Through Intelligent Procedures in Medication: The PSIP Project; Human Factors Engineering for Computer-Supported Identification and Prevention of Adverse Drug Events; Decision Support to Avoid Medication Errors . How Far Have We Come in Denmark and What Are the Present Challenges
ReMINE: An Ontology-Based Risk Management PlatformThe EU-ADR Project: Preliminary Results and Perspective; DebugIT: Building a European Distributed Clinical Data Mining Network to Foster the Fight Against Microbial Diseases; Part B. Detection and Prevention of Adverse Drug Events; Detection of Adverse Drug Events: Proposal of a Data Model; Detection of Adverse Drug Events Detection: Data Agregation and Data Mining; The Expert Explorer: A Tool for Hospital Data Visualization and Adverse Drug Event Rules Validation; Application of the Apriori Algorithm for Adverse Drug Reaction Detection Adverse Drug Events Prevention Rules: Multi-Site Evaluation of Rules from Various SourcesAutomatic Indexing in a Drug Information Portal; Implementation of SNOMED CT to the Medicines Database of a General Hospital; A Knowledge Engineering Framework Towards Clinical Support for Adverse Drug Event Prevention: The PSIP Approach; Strategy for Implementation and First Results of Advanced Clinical Decision Support in Hospital Pharmacy Practice Inevitable Components of and Steps for ADE Management Systems: The Need for a Unified Ontological Framework (UOF) and a More Effective Collaboration in Medication SafetyComputerised Physician Order Entry (CPOE); Part C. Human Factors and Adverse Drug Events; CPOE, Alerts and Workflow: Taking Stock of Ten Years Research at Erasmus MC; Contribution of Human Factors for the Review of Automatically Detected ADE; A Framework for Diagnosing and Identifying Where Technology-Induced Errors Come from; Gaming Against Medical Errors: Methods and Results from a Design Game on CPOE The PSIP Approach to Account for Human Factors in Adverse Drug Events: Preliminary Field StudiesThe Problem of Defensive Medicine: Two Italian Surveys; Subject Index; Author Index |
| Record Nr. | UNINA-9910781059603321 |
| Amsterdam ; ; Washington D.C., : IOS Press, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Emerging safety science [[electronic resource] ] : workshop summary / / Sally Robinson, Robert Pool, and Robert Giffin [rapporteurs] ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
| Emerging safety science [[electronic resource] ] : workshop summary / / Sally Robinson, Robert Pool, and Robert Giffin [rapporteurs] ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, c2008 |
| Descrizione fisica | xvi, 134 p. : ill. (some col.) |
| Disciplina | 615/.10289 |
| Altri autori (Persone) |
RobinsonSally
PoolRobert GiffinRobert B |
| Soggetto topico |
Drugs - United States - Safety measures
Pharmaceutical biotechnology - United States Drugs - United States - Design |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-281-30023-3
9786611300234 0-309-11013-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910454583503321 |
| Washington, D.C., : National Academies Press, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Emerging safety science [[electronic resource] ] : workshop summary / / Sally Robinson, Robert Pool, and Robert Giffin [rapporteurs] ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
| Emerging safety science [[electronic resource] ] : workshop summary / / Sally Robinson, Robert Pool, and Robert Giffin [rapporteurs] ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, c2008 |
| Descrizione fisica | xvi, 134 p. : ill. (some col.) |
| Disciplina | 615/.10289 |
| Altri autori (Persone) |
RobinsonSally
PoolRobert GiffinRobert B |
| Soggetto topico |
Drugs - United States - Safety measures
Pharmaceutical biotechnology - United States Drugs - United States - Design |
| ISBN |
0-309-17817-7
1-281-30023-3 9786611300234 0-309-11013-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910782897703321 |
| Washington, D.C., : National Academies Press, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Emerging safety science : workshop summary / / Sally Robinson, Robert Pool, and Robert Giffin [rapporteurs] ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
| Emerging safety science : workshop summary / / Sally Robinson, Robert Pool, and Robert Giffin [rapporteurs] ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, c2008 |
| Descrizione fisica | xvi, 134 p. : ill. (some col.) |
| Disciplina | 615/.10289 |
| Altri autori (Persone) |
RobinsonSally
PoolRobert GiffinRobert B |
| Soggetto topico |
Drugs - United States - Safety measures
Pharmaceutical biotechnology - United States Drugs - United States - Design |
| ISBN |
0-309-17817-7
1-281-30023-3 9786611300234 0-309-11013-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Front Matter -- Reviewers -- Preface -- Contents -- Tables and Figures -- 1 Introduction -- 2 Investigative Toxicology: The State of the Art -- 3 Screening Technologies I: Human Cell-Based Approaches -- 4 Screening Technologies II: Toxicogenomics -- 5 Screening Technologies III: Metabolomics -- 6 Screening Technologies IV: Pharmacogenetics -- 7 Qualifying Biomarkers -- 8 Pharmacovigilance -- 9 Integration -- 10 The Future of Safety Science -- References -- Appendixes -- Appendix A: Workshop Agenda -- Appendix B: Speaker Biographies. |
| Record Nr. | UNINA-9910964101503321 |
| Washington, D.C., : National Academies Press, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Safe Handling of Hazardous Drugs (Fourth Edition)
| Safe Handling of Hazardous Drugs (Fourth Edition) |
| Autore | Olsen MiKaela M |
| Edizione | [4th ed.] |
| Pubbl/distr/stampa | Pittsburgh : , : Oncology Nursing Society, , 2024 |
| Descrizione fisica | 1 online resource (146 pages) |
| Disciplina | 615/.10289 |
| Altri autori (Persone) | WaltonAnnMarie L |
| Soggetto topico |
Hazardous Substances
Occupational Exposure - prevention & control Drug-Related Side Effects and Adverse Reactions - prevention & control Safety Management - methods Chemical Safety - standards Health Personnel |
| ISBN |
9781635930641
1635930642 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Contents -- Foreword -- Definition of Hazardous Drugs -- Key Points -- Adverse Effects of Hazardous Drug Exposure -- Key Points -- Genotoxicity and Carcinogenicity of Hazardous Drug Exposure -- Adverse Reproductive Health Outcomes of Occupational Hazardous Drug Exposure -- Evidence for Occupational Hazardous Drug Exposure -- Key Points -- Biologic Monitoring -- Environmental Monitoring -- Interventions to Reduce Healthcare Worker Exposure -- Key Points -- Engineering Controls -- Containment Supplemental Engineering Controls -- Administrative Controls -- Work Practice Controls -- Personal Protective Equipment -- Drug Compounding -- Key Points -- General Information -- Containment Primary Engineering Control Work Practices -- Limitations Specific to Class II Biosafety Cabinets -- Personal Protective Equipment in a Containment Primary Engineering Control -- Preparing to Work in a Containment Primary Engineering Control -- Environmental Control Inside the Containment Primary Engineering Control -- Compounding of Sterile Hazardous Drugs -- Closed-System Drug-Transfer Devices -- Negative-Pressure Technique -- Spiking IV Bags and Priming Lines -- Nonsterile Hazardous Drug Compounding -- Robotic Compounding of Hazardous Drugs -- Safety Measures: Drug Labeling and Signage -- Receiving Hazardous Drugs -- Disposal of Compounding Supplies -- Drug Administration -- Key Points -- Intravenous Infusions -- Intravenous Push Administration -- Subcutaneous and Intramuscular Administration -- Oral Administration -- Enteral Tube Delivery -- Topical Hazardous Drugs -- Other Administration Routes -- Other Settings for Hazardous Drug Administration -- Postadministration Issues -- Key Points -- Urine and Feces -- Other Routes of Exposure -- Breastfeeding -- Additional Safe Handling Strategies -- Linen Handling -- Key Points -- Environmental Decontamination.
Key Points -- Management of Spills -- Key Points -- Respiratory Protection During Spill Cleanup -- Procedure for Cleanup of Hazardous Drug Spills -- Acute Exposure -- Follow-Up -- Disposal of Hazardous Drugs and Hazardous Drug Waste -- Key Points -- Trace Hazardous Drug Waste -- Managing Hazardous Waste Containers -- Medical Surveillance of Healthcare Workers Handling Hazardous Drugs -- Key Points -- What Is Medical Surveillance? -- Data Elements in a Medical Surveillance Program -- Measures of Genotoxicity -- Acute Exposure Follow-Up -- Documentation -- Essential Components for Medical Surveillance -- Temporary Reassignment/Alternative Duty -- Healthcare Worker Education and Training -- Key Points -- Educational Strategies -- Adult Learning -- Initial Education and Training -- Periodic Education and Training -- Healthcare Worker Education for Unique Routes of Administration and Settings -- Informal Education -- Innovative Strategies -- Overcoming Barriers to Safe Handling Practices -- Patient and Family Member/Caregiver Education -- Key Points -- Family Member and Caregiver Hazardous Drug Exposure -- Content of Patient Education for Safe Handling -- Routes of Exposure -- Preventing Surface Contamination at Home -- Personal Protective Equipment -- Safe Handling of Oral Hazardous Drugs -- Safe Handling Following Bladder Instillation -- Linen Handling at Home -- Hazardous Drug Spills in the Home -- The Hazardous Drug Handling Policy Landscape -- Key Points -- Federal Efforts: Occupational Safety and Health Administration and National Institute for Occupatio -- State Initiatives -- Professional Organizations -- Institutional Policy -- Resources for Advocacy and Health Policy -- Implications for Nursing -- Appendices -- Appendix A. Handling of Hazardous Drugs Healthcare Worker Agreement: Example -- Appendix B. Hazardous Drug Safe Handling Checklist. Appendix C. Hazardous Drug Administration Practicum -- Appendix D. Safe Management of Hazardous Drugs in the Home for Patients and Family Members/Caregiver -- References -- Index. |
| Record Nr. | UNINA-9911026006203321 |
Olsen MiKaela M
|
||
| Pittsburgh : , : Oncology Nursing Society, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||